Global Thalassemia Market Size study & Forecast, by Therapeutic Class (Iron Chelating Drugs), by Pipeline (Gene Therapy) and Regional Analysis, 2022-2029

Description

List of Tables

Global Thalassemia Market is valued approximately USD 2.58 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 5% over the forecast period 2022-2029. According to Centers for Disease Control and Prevention - Thalassemia can be defined as an inherited blood disorder caused when the body doesn't make enough hemoglobin. Hemoglobin is an important part of red blood cells. Thalassemia is a treatable disorder that can be well-managed with blood transfusions and chelation therapy. There are different types of signs and symptoms associated with thalassemia including Fatigue. Weakness, Pale or yellowish skin, Facial bone deformities, Slow growth, Abdominal swelling., and Dark urine among others. The increasing prevalence of blood disorders and growing adoption of blood transfusion and iron chelation therapies are key factors driving the market growth.

The increasing prevalence of blood disorders is contributing towards the growth of the Global Thalassemia Market. For instance - according to Indian Academy of Pediatrics (IPA) estimates - as of 2021, approximately 10% of the total world incidence of thalassemia-affected children and one in eight of thalassemia carriers live in India. Additionally, as per World Health organization (WHO) estimates - Beta-thalassemia affects 2.9% of the world's population. Also, growing healthcare industry in developing regions and increasing number of clinical trials for blood disorders would create lucrative growth prospectus for the market over the forecast period. However, the high cost associated with Thalassemia treatment stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Thalassemia Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the growing incidences of thalassemia and rise in spending in health infrastructure in the region. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, and growing incidences of blood related disorders as well as rapid expansion of contract manufacturing organizations in the region.

Major market player included in this report are:

Bluebird Bio Inc.
Acceleron Pharma, Inc.
Celgene Corporation
GlaxoSmithKline plc
Incyte Corporation
Gamida Cell
Kiadis Pharma
La Jolla Pharmaceutical Company
IONIS Pharmaceuticals
Novartis AG

Recent Developments in the Market:

In August 2022, the U.S. Food and Drug Administration approved Zynteglo (betibeglogene autotemcel), the first cell-based gene therapy intended for the treatment of adult and pediatric patients affected by beta-thalassemia.

Global Thalassemia Market Report Scope:

Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Therapeutic Class, Pipeline, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Therapeutic Class:

Iron Chelating Drugs

By Pipeline:

Gene Therapy

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
- 1.2.1. Thalassemia Market, by Region, 2019-2029 (USD Billion)
- 1.2.2. Thalassemia Market, by Therapeutic Class, 2019-2029 (USD Billion)
- 1.2.3. Thalassemia Market, by Pipeline, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Thalassemia Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Thalassemia Market Dynamics

3.1. Thalassemia Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
  - 3.1.1.1. Increasing prevalence of blood disorders
  - 3.1.1.2. Growing adoption of blood transfusion and iron chelation therapies
- 3.1.2. Market Challenges
  - 3.1.2.1. High Cost associated with treatment of Thalassemia
- 3.1.3. Market Opportunities
  - 3.1.3.1. Growing healthcare industry in developing regions
  - 3.1.3.2. Increasing number of clinical trials for blood disorders

Chapter 4. Global Thalassemia Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Thalassemia Market, by Therapeutic Class

6.1. Market Snapshot
6.2. Global Thalassemia Market by Therapeutic Class, Performance - Potential Analysis
6.3. Global Thalassemia Market Estimates & Forecasts by Therapeutic Class 2019-2029 (USD Billion)
6.4. Thalassemia Market, Sub Segment Analysis
- 6.4.1. Iron Chelating Drugs

Chapter 7. Global Thalassemia Market, by Pipeline

7.1. Market Snapshot
7.2. Global Thalassemia Market by Pipeline, Performance - Potential Analysis
7.3. Global Thalassemia Market Estimates & Forecasts by Pipeline 2019-2029 (USD Billion)
7.4. Thalassemia Market, Sub Segment Analysis
- 7.4.1. Gene Therapy

Chapter 8. Global Thalassemia Market, Regional Analysis

8.1. Thalassemia Market, Regional Market Snapshot
8.2. North America Thalassemia Market
- 8.2.1. U.S. Thalassemia Market
  - 8.2.1.1. Therapeutic Class breakdown estimates & forecasts, 2019-2029
  - 8.2.1.2. Pipeline breakdown estimates & forecasts, 2019-2029
- 8.2.2. Canada Thalassemia Market
8.3. Europe Thalassemia Market Snapshot
- 8.3.1. U.K. Thalassemia Market
- 8.3.2. Germany Thalassemia Market
- 8.3.3. France Thalassemia Market
- 8.3.4. Spain Thalassemia Market
- 8.3.5. Italy Thalassemia Market
- 8.3.6. Rest of Europe Thalassemia Market
8.4. Asia-Pacific Thalassemia Market Snapshot
- 8.4.1. China Thalassemia Market
- 8.4.2. India Thalassemia Market
- 8.4.3. Japan Thalassemia Market
- 8.4.4. Australia Thalassemia Market
- 8.4.5. South Korea Thalassemia Market
- 8.4.6. Rest of Asia Pacific Thalassemia Market
8.5. Latin America Thalassemia Market Snapshot
- 8.5.1. Brazil Thalassemia Market
- 8.5.2. Mexico Thalassemia Market
- 8.5.3. Rest of Latin America Thalassemia Market
8.6. Rest of The World Thalassemia Market

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies
9.2. Company Profiles
- 9.2.1. Bluebird Bio Inc.
  - 9.2.1.1. Key Information
  - 9.2.1.2. Overview
  - 9.2.1.3. Financial (Subject to Data Availability)
  - 9.2.1.4. Product Summary
  - 9.2.1.5. Recent Developments
- 9.2.2. Acceleron Pharma, Inc.
- 9.2.3. Celgene Corporation
- 9.2.4. GlaxoSmithKline plc
- 9.2.5. Incyte Corporation
- 9.2.6. Gamida Cell
- 9.2.7. Kiadis Pharma
- 9.2.8. La Jolla Pharmaceutical Company
- 9.2.9. IONIS Pharmaceuticals
- 9.2.10. Novartis AG

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Thalassemia Market, report scope
TABLE 2. Global Thalassemia Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Thalassemia Market estimates & forecasts by Therapeutic Class 2019-2029 (USD Billion)
TABLE 4. Global Thalassemia Market estimates & forecasts by Pipeline 2019-2029 (USD Billion)
TABLE 5. Global Thalassemia Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Thalassemia Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Thalassemia Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Thalassemia Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Thalassemia Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Thalassemia Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Thalassemia Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Thalassemia Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Thalassemia Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Thalassemia Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Thalassemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Thalassemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Thalassemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Thalassemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Thalassemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Thalassemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Thalassemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Thalassemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Thalassemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Thalassemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Thalassemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Thalassemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Thalassemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Thalassemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Thalassemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Thalassemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Thalassemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Thalassemia Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Thalassemia Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Thalassemia Market
TABLE 70. List of primary sources, used in the study of global Thalassemia Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

FIG 1. Global Thalassemia Market, research methodology
FIG 2. Global Thalassemia Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Thalassemia Market, key trends 2021
FIG 5. Global Thalassemia Market, growth prospects 2022-2029
FIG 6. Global Thalassemia Market, porters 5 force model
FIG 7. Global Thalassemia Market, pest analysis
FIG 8. Global Thalassemia Market, value chain analysis
FIG 9. Global Thalassemia Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Thalassemia Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Thalassemia Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Thalassemia Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Thalassemia Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Thalassemia Market, regional snapshot 2019 & 2029
FIG 15. North America Thalassemia Market 2019 & 2029 (USD Billion)
FIG 16. Europe Thalassemia Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Thalassemia Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Thalassemia Market 2019 & 2029 (USD Billion)
FIG 19. Global Thalassemia Market, company Market share analysis (2021)